Agomab Therapeutics NV (AGMB) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-04-16
09:14 am
Purchase
2026-03-3113GAGOMAB THERAPEUTICS NV
AGMB
Pontifax VI G.P. L.P.3,305,846
6.800%
3,305,846increase
(New Position)
Filing
History
2026-03-06
10:05 am
Purchase
2026-02-2713GAGOMAB THERAPEUTICS NV
AGMB
FMR LLC4,873,680
10.000%
4,873,680increase
(New Position)
Filing
History
2026-02-17
07:00 am
Purchase
2026-02-0913DAGOMAB THERAPEUTICS NV
AGMB
LSP 7 Cooperatieve U.A.5,141,992
10.600%
5,141,992increase
(New Position)
Filing
History